Physician profile
Jonathan David Steinberg
NPI 1295833671
$618.90
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $60.68 · 2021: $244 · 2022: $62.20.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $279.08 | 2019-2022 | |
| Organogenesis INC. | $108.81 | 2019 | |
| Zimmer Biomet Holdings, INC. | $39.19 | 2020-2021 | |
| Stryker Corporation | $34.61 | 2019 | |
| Bioventus LLC | $29.31 | 2021 | |
| Integra Lifesciences Corporation | $21.11 | 2020 | |
| Grt US Holding, INC. | $17.88 | 2021 | |
| Paragon 28, INC. | $17.63 | 2019 | |
| Medline Industries LP | $16.80 | 2019 | |
| Alfasigma USA, INC. | $16.53 | 2022 | |
| Orthofix Medical, INC. | $14.33 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.03 | 2021 | |
| Arthrosurface Incorporated | $10.59 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.